TARGETING IFNβ-REGULATED SECRETORY PROFILES TO OVERCOME ACQUIRED ANTI-PD-L1 RESISTANCE

被引：0
|
作者：
Shi, Yuhao [1 ]
Dolan, Melissa [1 ]
Mastri, Michalis [1 ]
Eng, Kevin [1 ]
Ebos, John [1 ]
机构：
[1] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2020年 / 8卷
关键词：
D O I：
10.1136/jitc-2020-SITC2020.0249
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
249
引用
收藏
页码：A150 / A150
页数：1
相关论文
共 50 条
  • [1] Targeting type I IFN-regulated secretory profiles to overcome acquired anti-PD-L1 resistance.
    Shi, Yuhao
    Dolan, Melissa
    Mastri, Michalis
    Hill, James W.
    Eng, Kevin
    Ebos, John M.
    CANCER RESEARCH, 2021, 81 (13)
  • [2] Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance
    Liang, Yong
    Tang, Haidong
    Guo, Jingya
    Qiu, Xiangyan
    Yang, Zecheng
    Ren, Zhenhua
    Sun, Zhichen
    Bian, Yingjie
    Xu, Lily
    Xu, Hairong
    Shen, Jiao
    Han, Yanfei
    Dong, Haidong
    Peng, Hua
    Fu, Yang-Xin
    NATURE COMMUNICATIONS, 2018, 9
  • [3] Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance
    Yong Liang
    Haidong Tang
    Jingya Guo
    Xiangyan Qiu
    Zecheng Yang
    Zhenhua Ren
    Zhichen Sun
    Yingjie Bian
    Lily Xu
    Hairong Xu
    Jiao Shen
    Yanfei Han
    Haidong Dong
    Hua Peng
    Yang-Xin Fu
    Nature Communications, 9
  • [4] Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Shi, Yuhao
    Mckenery, Amber
    Dolan, Melissa
    Mastri, Michalis
    Hill, James W.
    Dommer, Adam
    Benzekry, Sebastien
    Long, Mark
    Abrams, Scott, I
    Puzanov, Igor
    Ebos, John M. L.
    EMBO REPORTS, 2025, 26 (02) : 521 - 559
  • [5] Tumor extracellular vesicles mediate anti-PD-L1 therapy resistance by decoying anti-PD-L1
    Jiming Chen
    Jie Yang
    Wenhui Wang
    Danfeng Guo
    Chengyan Zhang
    Shibo Wang
    Xinliang Lu
    Xiaofang Huang
    Pingli Wang
    Gensheng Zhang
    Jing Zhang
    Jianli Wang
    Zhijian Cai
    Cellular & Molecular Immunology, 2022, 19 : 1290 - 1301
  • [6] Tumor extracellular vesicles mediate anti-PD-L1 therapy resistance by decoying anti-PD-L1
    Chen, Jiming
    Yang, Jie
    Wang, Wenhui
    Guo, Danfeng
    Zhang, Chengyan
    Wang, Shibo
    Lu, Xinliang
    Huang, Xiaofang
    Wang, Pingli
    Zhang, Gensheng
    Zhang, Jing
    Wang, Jianli
    Cai, Zhijian
    CELLULAR & MOLECULAR IMMUNOLOGY, 2022, 19 (11) : 1290 - 1301
  • [7] Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours
    Melero, Ignacio
    de Miguel Luken, Maria
    de Velasco, Guillermo
    Garralda, Elena
    Martin-Liberal, Juan
    Joerger, Markus
    Alonso, Guzman
    Goebeler, Maria-Elisabeth
    Schuler, Martin
    Koenig, David
    Dummer, Reinhard
    Reig, Maria
    Rodriguez Ruiz, Maria-Esperanza
    Calvo, Emiliano
    Esteban-Villarrubia, Jorge
    Oberoi, Arjun
    Sabat, Paula
    Soto-Castillo, Juan Jose
    Koster, Kira-Lee
    Saavedra, Omar
    Sayehli, Cyrus
    Gromke, Tanja
    Laeubli, Heinz
    Ramelyte, Egle
    Fortuny, Marta
    Landa-Magdalena, Ana
    Moreno, Irene
    Torres-Jimenez, Javier
    Hernando-Calvo, Alberto
    Hess, Dagmar
    Racca, Fabricio
    Richly, Heike
    Schmitt, Andreas M.
    Eggenschwiler, Corinne
    Sanduzzi-Zamparelli, Marco
    Vilalta-Lacarra, Anna
    Trojan, Joerg
    Koch, Christine
    Galle, Peter R.
    Foerster, Friedrich
    Trajanoski, Zlatko
    Hackl, Hubert
    Gogolla, Falk
    Koll, Florestan J.
    Wild, Peter
    Chun, Felix Kyoung Hwan
    Reis, Henning
    Lloyd, Peter
    Machacek, Matthias
    Gajewski, Thomas F.
    NATURE, 2025, 637 (8048) : 1218 - 1227
  • [8] Targeting type I interferon tumor entry by anti-PD-L1 creates feedforward antitumor responses to overcome innate and adaptive resistance
    Tang, Haidong
    Liang, Yong
    Guo, Jingya
    Qiu, Xiangyan
    Peng, Hua
    Fu, Yang-Xin
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [9] Overcoming resistance to anti-PD1 and anti-PD-L1 treatment in gastrointestinal malignancies
    Puccini, Alberto
    Battaglin, Francesca
    Iaia, Maria Laura
    Lenz, Heinz-Josef
    Salem, Mohamed E.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [10] Benefit with anti-PD-L1
    Diana Romero
    Nature Reviews Clinical Oncology, 2017, 14 : 71 - 71
12345